Central Pacific Bank Trust Division lifted its position in Oracle Co. (NYSE:ORCL - Free Report) by 30.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,025 shares of the enterprise software provider's stock after acquiring an additional 7,029 shares during the quarter. Central Pacific Bank Trust Division's holdings in Oracle were worth $4,198,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in the company. McClarren Financial Advisors Inc. lifted its holdings in shares of Oracle by 201.7% in the 4th quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider's stock worth $266,000 after purchasing an additional 1,069 shares during the last quarter. Crews Bank & Trust bought a new stake in shares of Oracle in the 4th quarter worth approximately $1,800,000. Boston Trust Walden Corp lifted its holdings in shares of Oracle by 40.8% in the 4th quarter. Boston Trust Walden Corp now owns 564,030 shares of the enterprise software provider's stock worth $93,990,000 after purchasing an additional 163,543 shares during the last quarter. CENTRAL TRUST Co lifted its holdings in shares of Oracle by 10.8% in the 4th quarter. CENTRAL TRUST Co now owns 43,851 shares of the enterprise software provider's stock worth $7,307,000 after purchasing an additional 4,259 shares during the last quarter. Finally, EQ Wealth Advisors LLC bought a new stake in shares of Oracle in the 4th quarter worth approximately $12,738,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Insider Buying and Selling
In other news, Director Naomi O. Seligman sold 2,866 shares of Oracle stock in a transaction on Monday, May 5th. The stock was sold at an average price of $149.53, for a total transaction of $428,552.98. Following the transaction, the director now owns 31,764 shares in the company, valued at approximately $4,749,670.92. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Leon E. Panetta sold 5,000 shares of Oracle stock in a transaction on Friday, April 11th. The shares were sold at an average price of $129.77, for a total value of $648,850.00. Following the transaction, the director now owns 58,090 shares in the company, valued at $7,538,339.30. This represents a 7.93% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,366 shares of company stock worth $4,015,723 in the last three months. 42.20% of the stock is currently owned by insiders.
Oracle Price Performance
Shares of NYSE ORCL traded up $2.13 during mid-day trading on Friday, reaching $165.03. The company had a trading volume of 17,537,919 shares, compared to its average volume of 9,527,386. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. The stock has a market cap of $461.58 billion, a PE ratio of 40.35, a P/E/G ratio of 3.46 and a beta of 1.27. The company has a 50-day moving average price of $144.55 and a two-hundred day moving average price of $161.07. Oracle Co. has a 1-year low of $117.34 and a 1-year high of $198.31.
Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). The company had revenue of $14.13 billion during the quarter, compared to analyst estimates of $14.40 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The business's revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.41 earnings per share. On average, equities analysts anticipate that Oracle Co. will post 5 earnings per share for the current year.
Oracle Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Thursday, April 10th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.21%. This is a boost from Oracle's previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Thursday, April 10th. Oracle's payout ratio is presently 46.95%.
Analysts Set New Price Targets
Several brokerages recently issued reports on ORCL. Barclays cut their price target on Oracle from $212.00 to $202.00 and set an "overweight" rating on the stock in a report on Tuesday, March 11th. Mizuho cut their target price on Oracle from $210.00 to $180.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Evercore ISI cut their target price on Oracle from $200.00 to $185.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. DA Davidson cut their target price on Oracle from $150.00 to $140.00 and set a "neutral" rating on the stock in a research note on Monday, April 14th. Finally, Cantor Fitzgerald cut their target price on Oracle from $214.00 to $175.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 11th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $174.42.
Check Out Our Latest Stock Analysis on ORCL
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report